These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17526995)

  • 1. Increased thrombogenesity in patients with cyanotic congenital heart disease.
    Kajimoto H; Nakazawa M; Murasaki K; Mori Y; Tanoue K; Kasanuki H; Nakanishi T
    Circ J; 2007 Jun; 71(6):948-53. PubMed ID: 17526995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients.
    Kajimoto H; Nakazawa M; Murasaki K; Hagiwara N; Nakanishi T
    Circ J; 2009 Sep; 73(9):1705-10. PubMed ID: 19638712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
    Horigome H; Murakami T; Isobe T; Nagasawa T; Matsui A
    Thromb Res; 2003; 112(4):223-7. PubMed ID: 14987915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia.
    Horigome H; Hiramatsu Y; Shigeta O; Nagasawa T; Matsui A
    J Am Coll Cardiol; 2002 Mar; 39(6):1072-7. PubMed ID: 11897453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombo-hemorrhagic liability in children with congenital heart diseases.
    Shebl SS; El-Shehaby WAN; Said YS; Darwish AH; Elfadaly NH; Amer E
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):123-128. PubMed ID: 28867175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of circulating platelets and platelet response to activating agents in children with cyanotic congenital heart disease: their relevance to palliative systemic-pulmonary shunt.
    Kierzkowska B; Stańczyk J; Wiectawska B; Rózalski M; Boncler M; Chrul S; Watala C
    Int J Cardiol; 2001 Jun; 79(1):49-59. PubMed ID: 11399341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease.
    Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G
    Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The young platelet population in children with cyanotic congenital heart disease.
    Goldschmidt B; Sorland SJ
    Thromb Haemost; 1976 Apr; 35(2):342-9. PubMed ID: 989634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived microparticles and platelet function profile in children with congenital heart disease.
    Ismail EA; Youssef OI
    Clin Appl Thromb Hemost; 2013; 19(4):424-32. PubMed ID: 22914812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease.
    Jensen AS; Johansson PI; Bochsen L; Idorn L; Sørensen KE; Thilén U; Nagy E; Furenäs E; Søndergaard L
    Int J Cardiol; 2013 Sep; 167(5):2210-4. PubMed ID: 22727966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of platelet count in pediatric patients with congenital cyanotic heart disease: Role of immature platelet fraction.
    Matter RM; Ragab IA; Roushdy AM; Ahmed AG; Aly HH; Ismail EA
    Congenit Heart Dis; 2018 Jan; 13(1):118-123. PubMed ID: 28880458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.
    Katayama S; Nunomiya S; Koyama K; Wada M; Koinuma T; Goto Y; Tonai K; Shima J
    Crit Care; 2017 Aug; 21(1):229. PubMed ID: 28841902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy.
    Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Satoh T; Nakanishi N
    Circulation; 2000 Nov; 102(22):2720-5. PubMed ID: 11094038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological reproducibility of circulating P-Selectin, Thrombopoietin, GPIIb/IIIa and Thrombomodulin over one year.
    Graf ME; Sookthai D; Johnson T; Schübel R; Katzke V; Bugert P; Hoffmeister M; Kaaks R; Kühn T
    Clin Biochem; 2017 Nov; 50(16-17):942-946. PubMed ID: 28571971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombomodulin in pediatric cardiac surgery.
    Boldt J; Knothe C; Schindler E; Welters A; Dapper FF; Hempelmann G
    Ann Thorac Surg; 1994 Jun; 57(6):1584-9. PubMed ID: 8010806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
    Blann AD; Lip GY; Beevers DG; McCollum CN
    Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications.
    Musolino C; Alonci A; Allegra A; Spatari G; Bellomo G; Tringali O; Quartarone C; Squadrito G; Quartarone M
    Am J Hematol; 1998 Feb; 57(2):109-12. PubMed ID: 9462541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein C activation in NIDDM patients.
    Gabazza EC; Takeya H; Deguchi H; Sumida Y; Taguchi O; Murata K; Nakatani K; Yano Y; Mohri M; Sata M; Shima T; Nishioka J; Suzuki K
    Diabetologia; 1996 Dec; 39(12):1455-61. PubMed ID: 8960826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations.
    Turner-Gomes SO; Mitchell L; Williams WG; Andrew M
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):562-8. PubMed ID: 8302075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.